Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 749

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 749
---
 2025 and May 9, 2025, Scilex deposited an aggregate of $1,750, drawn down from the Extension Scilex Convertible Promissory Note, to the Trust
Account to extend the time the Company has to consummate an initial business combination from April 11, 2025 to June 11, 2025. On June 11, 2025, Scilex deposited an additional $874.78, drawn down from the Extension Scilex Convertible Promissory
Note, to the Trust Account to extend the time the Company has to consummate an initial business combination to July 11, 2025. On July 11,

F-33

2025, Scilex deposited an additional $874.78, drawn down from the Extension Scilex Convertible Promissory Note, to the Trust Account to extend the time the Company has to consummate an initial
business combination to August 11, 2025.

On July 22, 2025, the Company entered into Amendment No. 2 to the Merger Agreement with Semnur and Merger
Sub (“Amendment No. 2”). Amendment No. 2 amends the Merger Agreement to, among other things, modify the definitions of the “Exchange Ratio” and “Merger Consideration” to facilitate the issuance of additional
shares of common stock of Semnur prior to the closing of the Business Combination in connection with any potential private placement financing or for issuance to advisors and other service providers for services rendered and maintain the 1.25-to-1
exchange ratio.

On August 11, 2025, Scilex deposited an additional $874.78, drawn down from the Extension Scilex Convertible Promissory Note, to the
Trust Account to extend the time the Company has to consummate an initial business combination to September 11, 2025.

F-34

DENALI CAPITAL ACQUISITION CORP. CONDENSED CONSOLIDATED BALANCE SHEETS

|                                                                                                                                                                          |     |            |   March 31, 
        2025 |   |     |   | December 31, 
         2024 |   |
|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-----------|------------:|:--|:----|:--|-------------:|:--|
|                                                                                                                                                                          |     | -Unaudited |             |   |     |   |              |